| Income Statement |
| Total Revenue | 935.17M |
|
| Revenues (USD) | 935.17M |
| Cost of Revenue | 599.32M |
| Gross Profit | 335.85M |
| Operating Expenses | 144.95M |
| Research and Development Expense | 44.51M |
| Selling, General and Administrative Expense | 100.44M |
| Operating Income | 190.91M |
| Interest Expense | 253.00K |
| Income Tax Expense | 33.57M |
| Net Income | 165.36M |
| Net Income Common Stock | 165.36M |
| Net Income Common Stock (USD) | 165.36M |
| Consolidated Income | 165.36M |
| Earnings per Basic Share | 1.10 |
| Earnings per Basic Share (USD) | 1.10 |
| Earnings per Diluted Share | 1.07 |
| Earning Before Interest & Taxes (EBIT) | 199.18M |
| Earning Before Interest & Taxes (USD) | 199.18M |
| Weighted Average Shares | 150.78M |
| Weighted Average Shares Diluted | 155.14M |
| Balance Sheet |
| Cash and Equivalents | 1.21B |
| Cash and Equivalents (USD) | 1.21B |
| Trade and Non-Trade Receivables | 444.71M |
| Current Assets | 3.03B |
| Property, Plant & Equipment Net | 89.18M |
| Total Assets | 4.26B |
| Current Liabilities | 1.13B |
| Total Liabilities | 1.71B |
| Accumulated Retained Earnings (Deficit) | -1.81B |
| Accumulated Other Comprehensive Income | 1.89M |
| Shareholders Equity | 2.56B |
| Shareholders Equity (USD) | 2.56B |
| Assets Non-Current | 1.23B |
| Deferred Revenue | 432.84M |
| Goodwill and Intangible Assets | 569.59M |
| Inventory | 261.63M |
| Liabilities Non-Current | 578.74M |
| Trade and Non-Trade Payables | 535.97M |
| Tax Assets | 509.01M |
| Tax Liabilities | 373.81M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 8.77M |
| Net Cash Flow from Financing | 19.76M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 118.92M |
| Capital Expenditure | -15.90M |
| Issuance (Purchase) of Equity Shares | 26.01M |
| Net Cash Flow from Investing | -21.90M |
| Net Cash Flow from Operations | 121.06M |